PRELUDE THERAPEUTICS INC
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $11.4M | $223.6M | $218.3M |
| FY2021 | $19.2M | $305.1M | $31.8M |
| FY2022 | $25.1M | $220.5M | $30.6M |
| FY2023 | $40.6M | $277.7M | $25.3M |
| FY2024 | $44.1M | $175.5M | $12.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $11.4M | $223.6M | $218.3M |
| FY2021 | $19.2M | $305.1M | $31.8M |
| FY2022 | $25.1M | $220.5M | $30.6M |
| FY2023 | $40.6M | $277.7M | $25.3M |
| FY2024 | $44.1M | $175.5M | $12.5M |